Renato Araujo Prates

Dr. Renato Araujo Prates

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Frontiers in Microbiology
Verified
Journal Article
Open access
Tianhong DaiTianhong Dai
Tianhong Dai
BFBeth B. Fuchs
Beth B. Fuchs
JCJeffrey J. Coleman
Jeffrey J. Coleman
Renato Araujo PratesRenato Araujo Prates
Renato Araujo Prates
CAChristos Astrakas
Christos Astrakas
GTGeorge P. Tegos
George P. Tegos
Opportunistic fungal pathogens may cause superficial or serious invasive infections, especially in immunocompromised and debilitated patients. Invasive mycoses represent an exponentially growing threat for human health due to a combination of slow diagnosis and the existence of relatively few classes of available and effective antifungal drugs. Therefore systemic fungal infections result in high attributable mortality. There is an urgent need to pursue and deploy novel and effective alternative antifungal countermeasures. Photodynamic therapy (PDT) was established as a successful modality for malignancies and age-related macular degeneration but photodynamic inactivation has only recently been intensively investigated as an alternative antimicrobial discovery and development platform. The concept of photodynamic inactivation requires microbial exposure to either exogenous or endogenous photosensitizer molecules, followed by visible light energy, typically wavelengths in the red/near infrared region that cause the excitation of the photosensitizers resulting in the production of singlet oxygen and other reactive oxygen species that react with intracellular components, and consequently produce cell inactivation and death. Antifungal PDT is an area of increasing interest, as research is advancing (i) to identify the photochemical and photophysical mechanisms involved in photoinactivation; (ii) to develop potent and clinically compatible photosensitizers; (iii) to understand how photoinactivation is affected by key microbial phenotypic elements multidrug resistance and efflux, virulence and pathogenesis determinants, and formation of biofilms; (iv) to explore novel photosensitizer delivery platforms; and (v) to identify photoinactivation applications beyond the clinical setting such as environmental disinfectants.

1 October 2006 in Photomedicine and Laser Surgery
Verified
Journal Article
Closed access
JAJosé Cláudio Faria Amorim
José Cláudio Faria Amorim
GSGerdal Roberto De Sousa
Gerdal Roberto De Sousa
LSLívio De Barros Silveira
Lívio De Barros Silveira
Renato Araujo PratesRenato Araujo Prates
Renato Araujo Prates
MPMarcos Pinotti
Marcos Pinotti
MRMartha Ribeiro
Martha Ribeiro
Objective: The purpose of this study was to investigate gingival healing after gingivectomy and adjunctive use of low-level laser therapy (LLLT). Background Data: LLLT has been used in animal experiments to examine the influence of laser radiation on the wound healing process since the 1960s. However, clinical trials in dentistry are scarce, and most of them refer to treatment after extraction of the third molars, with only a few reports in the area of periodontics. Methods: Twenty patients with periodontal disease were selected, and treatment was planned for gingivectomy to bilateral maxillary and mandibular premolar teeth. After surgery, one side was submitted to LLLT using a 685-nm wavelength, output power of 50 mW, and energy density of 4 J/cm 2 . The other side was used as the control and did not receive laser irradiation. Healing was evaluated, clinically and biometrically, immediately post-surgery and at days 3, 7, 14, 21, 28, and 35. Results were submitted to statistical analysis. Results: Biometrical evaluation indicated a significant improvement in healing for the laser group at 21 and 28 days. Clinical evaluation showed better repair for the laser group, mainly after the third day. Conclusion: LLLT was an effective adjunctive treatment that appeared to promote healing following gingivectomy.

1 January 2007 in Journal of Photochemistry and Photobiology B: Biology
Verified
Journal Article
Closed access
Renato Araujo PratesRenato Araujo Prates
Renato Araujo Prates
AYAécio Massayoshi Yamada
Aécio Massayoshi Yamada
LSLuis Cláudio Suzuki
Luis Cláudio Suzuki
MHMaria Cristina Eiko Hashimoto
Maria Cristina Eiko Hashimoto
SCSilvana Cai
Silvana Cai
MRMartha Ribeiro
Martha Ribeiro

26 April 2011 in Journal of Antimicrobial Chemotherapy
Verified
Journal Article
Open access
PDF file
Renato Araujo PratesRenato Araujo Prates
Renato Araujo Prates
IKIlka T. Kato
Ilka T. Kato
MRMartha Ribeiro
Martha Ribeiro
GTGeorge P. Tegos
George P. Tegos
Michael R. HamblinMichael R. Hamblin
Michael R. Hamblin
To investigate whether the major fungal multidrug efflux systems (MESs) affect the efficiency of methylene blue (MB)-mediated antimicrobial photodynamic inactivation (APDI) in pathogenic fungi and test specific inhibitors of these efflux systems to potentiate APDI. Candida albicans wild-type and mutants that overexpressed two classes of MESs [ATP-binding cassette (ABC) and major facilitator superfamily (MFS)] were tested for APDI using MB as the photosensitizer with and without addition of MES inhibitors. The uptake and cytoplasm localization of photosensitizer were achieved using laser confocal microscopy. ABC MES overexpression reduced MB accumulation and APDI killing more than MFS MES overexpression. Furthermore, by combining MB APDI with the ABC inhibitor verapamil, fungal killing and MB uptake were potentiated, while by combining MB APDI with the MFS inhibitor INF271, fungal killing and MB uptake were inhibited. This latter surprising finding may be explained by the hypothesis that the MFS channel can also serve as an uptake mechanism for MB. The ABC pumps are directly implicated in MB efflux from the cell cytoplasm. Both the influx and efflux of MB may be regulated by MFS systems, and blocking this gate before incubation with MB can decrease the uptake and APDI effects. An ABC inhibitor could be usefully combined with MB APDI for treating C. albicans infections.

30 March 2012 in Photochemistry and Photobiology
Verified
Journal Article
Closed access
PDF file
MHMaria C. E. Hashimoto
Maria C. E. Hashimoto
Renato Araujo PratesRenato Araujo Prates
Renato Araujo Prates
IKIlka T. Kato
Ilka T. Kato
SNSilvia C. Núñez
Silvia C. Núñez
LCLilia Courrol
Lilia Courrol
MRMartha Ribeiro
Martha Ribeiro

1 January 2013 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
IKIlka Tiemy Kato
Ilka Tiemy Kato
Renato Araujo PratesRenato Araujo Prates
Renato Araujo Prates
CSCaetano Padial Sabino
Caetano Padial Sabino
BFBeth Burgwyn Fuchs
Beth Burgwyn Fuchs
GTGeorge P. Tegos
George P. Tegos
MRMartha Ribeiro
Martha Ribeiro
The objective of this study was to evaluate whether Candida albicans exhibits altered pathogenicity characteristics following sublethal antimicrobial photodynamic inactivation (APDI) and if such alterations are maintained in the daughter cells. C. albicans was exposed to sublethal APDI by using methylene blue (MB) as a photosensitizer (0.05 mM) combined with a GaAlAs diode laser (λ 660 nm, 75 mW/cm 2 , 9 to 27 J/cm 2 ). In vitro , we evaluated APDI effects on C. albicans growth, germ tube formation, sensitivity to oxidative and osmotic stress, cell wall integrity, and fluconazole susceptibility. In vivo , we evaluated C. albicans pathogenicity with a mouse model of systemic infection. Animal survival was evaluated daily. Sublethal MB-mediated APDI reduced the growth rate and the ability of C. albicans to form germ tubes compared to untreated cells ( P < 0.05). Survival of mice systemically infected with C. albicans pretreated with APDI was significantly increased compared to mice infected with untreated yeast ( P < 0.05). APDI increased C. albicans sensitivity to sodium dodecyl sulfate, caffeine, and hydrogen peroxide. The MIC for fluconazole for C. albicans was also reduced following sublethal MB-mediated APDI. However, none of those pathogenic parameters was altered in daughter cells of C. albicans submitted to APDI. These data suggest that APDI may inhibit virulence factors and reduce in vivo pathogenicity of C. albicans . The absence of alterations in daughter cells indicates that APDI effects are transitory. The MIC reduction for fluconazole following APDI suggests that this antifungal could be combined with APDI to treat C. albicans infections.